Fig. 3
From: Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients
Soluble E-selectin correlates with fractalkine release after intravenous injection of endotoxin in healthy humans in vivo but is not associated with increased mortality in sepsis patients. a Fractalkine release after intravenous injection of endotoxin (lipopolysaccharide, 4 ng/kg body weight) into five healthy subjects compared with E-selectin release. Right panel shows correlation between fractalkine levels and E-selectin measured during the first 5 hours after endotoxin administration (shaded gray). Data are expressed as mean ± standard error of the mean. b Soluble E-selectin levels were elevated in patients compared to healthy volunteers (HV) at all time points. c Soluble E-selectin levels of survivors and non-survivors at day 30, presented as box and whiskers as specified by Tukey. ***P <0.001, **P <0.01, *P <0.05